Vanda Pharmaceuticals | VNDA - EPS - Lucro por Ação





Eps Alterar Data
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
Akebia Therapeutics USD -0.04 0.04 2025-12
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD -1.36 0.43 2026-06
AstraZeneca USD 2.63 0.05 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Halozyme Therapeutics USD 2.28 0.68 2026-06
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -0.06 0.7 2026-06
J&J USD 2.9 0.2 2026-06
Lexicon Pharmaceuticals USD -0.04 0.01 2025-12
Ligand Pharmaceuticals USD 2.37 0.74 2026-06
Merck USD -0.13 1.15 2026-06
Minerva Neurosciences USD -0.56 3.53 2024-12
Moderna USD -1.97 1.43 2026-06
Novartis USD 1.99 0.45 2026-03
Pfizer USD 0.77 0.02 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 2.09 0.21 2026-06
Takeda JPY 71.65 87.21 2026-06
Teva Pharmaceutical Industries USD 0.06 1.51 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Vanda Pharmaceuticals USD -0.09 0 2024-12
Veracyte USD 0.54 0.02 2026-06